Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 133Lung Neoplasms 74Brain Neoplasms 27Small Cell Lung Carcinoma 15Melanoma 13Breast Neoplasms 12Neoplasm Metastasis 11Neoplasms 9Carcinoma, Renal Cell 7Adenocarcinoma of Lung 7Prostatic Neoplasms 6NSCLC 5Urinary Bladder Neoplasms 4Recurrence 3Liver Neoplasms 3Kidney Neoplasms 3Gastrointestinal Neoplasms 3Carcinoma, Bronchogenic 3Bronchial Neoplasms 3Breast Neoplasms, Male 3Thoracic Neoplasms 2Sarcoma 2Respiratory Tract Neoplasms 2Respiratory Tract Diseases 2Neoplasms by Site 2Mesothelioma 2Head and Neck Neoplasms 2Colorectal Neoplasms 2Carcinoma, Squamous Cell 2Carcinoma, Neuroendocrine 2

Interventions

lorlatinib 3pembrolizumab 2osimertinib 2Radiotherapy 2atezolizumab 1Temozolomide 1Radiosurgery 1Paclitaxel 1Nivolumab 1Ipilimumab 1Fecal Microbiota Transplantation 1Carboplatin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Non Small Cell Lung Cancer Metastatic × Radiosurgery × Thoracic × Clear all
NCT06741085 2026-04-13

A Study of Stereotactic Radiosurgery (SRS) and Standard Treatment in People With Lung Cancer That Has Spread to the Brain

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
56 enrolled
Thoracic

Non Small Cell Lung Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡